HCRN GU Cancers Industry Showcase
Tuesday, May 13, 2025
2-4 pm ET / 1-3 pm CT / 12-2 pm MT / 11 am – 1 pm PT
This virtual seminar will showcase recent advances in diagnostics, artificial intelligence, and therapeutic pipelines applicable to genitourinary malignancies, including bladder, kidney, and prostate cancers.
Hosted by the HCRN GU and Correlative Sciences Clinical Trial Working Groups, this seminar will feature rapid presentations by leading commercial labs and pharmaceutical companies. The seminar is open to all investigators across the HCRN network, and is designed especially for those with interest and expertise in genitourinary medical oncology, radiation oncology, surgical oncology, radiology, translational science, and urology.
Presenting Companies:
- Artera
- AstraZeneca
- Boston Gene
- Exelixis
- Foundation Medicine
- Haystack
- Johnson&Johnson
- Natera
- Novartis
- Tempus
